Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study

Farhana Islam, Leen Magarbeh, Samar S.M. Elsheikh, Stefan Kloiber, Caroline W. Espinola, Venkat Bhat, Benicio N. Frey, Roumen Milev, Claudio N. Soares, Sagar V. Parikh, Franca Placenza, Stefanie Hassel, Valerie H. Taylor, Francesco Leri, Pierre Blier, Rudolf Uher, Faranak Farzan, Raymond W. Lam, Gustavo Turecki, Jane A. FosterSusan Rotzinger, Sidney H. Kennedy, Daniel J. Müller

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
Original languageEnglish
JournalCanadian Journal of Psychiatry
DOIs
Publication statusAccepted/In press - 2023
Externally publishedYes

ASJC Scopus Subject Areas

  • Psychiatry and Mental health

Keywords

  • ABCB1
  • adverse events
  • Antidepressants
  • aripiprazole
  • CYP2C19
  • CYP2D6
  • depression
  • escitalopram
  • pharmacogenetics
  • sexual dysfunction

Fingerprint

Dive into the research topics of 'Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study'. Together they form a unique fingerprint.

Cite this